MARK W. KROLL - 26 May 2021 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role: Director
Signature: /s/ Thomas V. Powers, attorney-in-fact for Dr. Kroll
Issuer symbol: HAE
Transactions as of: 26 May 2021
Net transactions value: -$283,339
Form type: 4
Filing time: 28 May 2021, 16:09:38 UTC
Previous filing: 14 May 2021
Next filing: 01 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HAE	Common Stock	Options Exercise	$367,557	+10,353	+52%	$35.50	30,253	26 May 2021	Direct	F1, F2
transaction	HAE	Common Stock	Sale	$650,896	-11,813	-39%	$55.10	18,440	26 May 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HAE	Non-qualified Stock Option (Right to Buy)	Options Exercise	$0	-10,353	-100%	$0.000000^*	0	26 May 2021	Common Stock	10,353	$35.50	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person exercised options that were granted in 2014 and scheduled to expire on July 23, 2021, as reflected in this Form 4.
F2	This number includes unvested restricted stock units previously reported.
F3	Option vests 100% on the first anniversary of the date of grant.